CRABP2 and ovarian serous adenocarcinoma: The analysis showed that patients with high expression of CRABP2 had a poorer prognosis (Fig. 1D), and multivariate survival analysis showed that CRABP2 was an independent prognostic factor for serous ovarian cancer patients (Table 1).